Parathyroid Hormone Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Parathyroid Hormone Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON , UK, October 24, 2022 /EINPresswire.com/ -- The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

As per The Business Research Company's "Parathyroid Hormone Global Market Report 2022”, the parathyroid hormone market is expected to reach $2.51 billion in 2026 at a CAGR of 4%. The rise in the prevalence of osteoporosis is expected to drive the parathyroid hormone market growth.

Request a Sample now to gain a better understanding of parathyroid hormone market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

Key Trends In The Parathyroid Hormone Market
According to the parathyroid hormone market research, companies are focusing on developing a biosimilar of parathyroid-based drugs. A biosimilar is a biological product that is developed to be similar to an already FDA-approved biologic, known as the reference product. Biosimilars potentially offer consumers the opportunity to reduce their health care costs without compromising on treatment standards, thus parathyroid hormone manufacturing companies are investing in it. For instance, in August 2019, Gedeon Richter announced the launch of biosimilar teriparatide caledTerrosa^® in Europe. In August 2020, Cadila Pharmaceuticals has launched a teriparatide biosimilar (NuPTH) meant for osteoporosis.

Overview Of The Parathyroid Hormone Market
The parathyroid hormone market consists of sales of parathyroid hormones and related services by entities (organizations, sole traders, and partnerships) that develop parathyroid hormones to treat various diseases. Parathyroid hormone is responsible for regulating the distribution of phosphate and calcium in the body and is used in the treatment of diseases such as hypothyroidism and osteoporosis.

Learn more on the global parathyroid hormone market report at:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Parathyroid Hormone Global Market Report 2022 from TBRC covers the following information:
Market Size Data
• Forecast period: Historical and Future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Market Segmentation
• By Disease Type: Hypocalcaemia, Hypoparathyroidism
• By End-User: Hospitals, Clinics, Other
• By Product Type: Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues
• By Geography: The global parathyroid hormone market report is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest share in the market.

Major market players such as Pfizer Inc, Eli Lilly and Company, Radius Health Inc, Shire, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc. and Gedeon Richter Plc.

Trends, opportunities, strategies and so much more.

Parathyroid Hormone Global Market Report 2022 is one of The Business Research Company’s comprehensive reports that provides an overview of parathyroid hormone global market. The market report analyzes parathyroid hormone global market size, parathyroid hormone global market growth drivers, parathyroid hormone global market segments, parathyroid hormone market major players, parathyroid hormone global market growth across geographies, and parathyroid hormone global market competitors’ revenues and market positioning. The parathyroid hormone global market report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.

Not what you were looking for? Go through similar reports by The Business Research Company:

Anti-Thyroid Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Metabolic Disorders Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Biosimilar Growth Hormones Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

About The Business Research Company

The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Check out our:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Market Research Products, Services, Solutions For Your Business - TBRC

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.